Investment

No money for UK biotech

The precarious position of the UK’s life sciences sector is underlined by fundraising failures among 295 of its members.
01 Apr 2009

Will Roche get what it paid for?

Beyond its blockbuster drugs Genentech has a commodity rare in a large company – an entrepreneurial culture. Can Roche preserve this?
18 Mar 2009

UK publishes 18th annual R&D scoreboard

The 850 UK firms making the largest investment R&D in 2007 grew their R&D by 6 per cent to £21.6 billion in the last year, according to the UK government's 18th annual R&D scoreboard.
28 Jan 2009